首页|基于网络药理学与分子对接探究乌梅丸"异病同治"胃肠及脑疾病的作用机制

基于网络药理学与分子对接探究乌梅丸"异病同治"胃肠及脑疾病的作用机制

扫码查看
目的 基于网络药理学与分子对接探讨乌梅丸能同时治疗胃肠及脑疾病的作用机制。方法 通过中药系统药理学数据库与分析平台(TCMSP)、PubChem、SwissTargetPrediction、Uniprot、GeneCards、BrainBase、STRING 以及 Metascape等数据库与Cytoscape构建一系列网络图,筛选核心成分、核心靶点及主要治疗疾病,并对靶基因进行GO分析和KEGG通路富集分析,最后通过AutoDock软件对关键活性成分与潜在作用靶点进行分子对接验证。结果 获得乌梅丸潜在活性成分102种,治疗胃肠及脑疾病的交集潜在靶点171个。KEGG富集分析主要涉及肿瘤信号通路、钙离子信号通路、乙型肝炎、HIF-1信号通路等。其中,为槲皮素、鬃毛酮、苦楝酮、五味子酯乙和benzoylnapelline可能是乌梅丸能同时治疗胃肠及脑疾病的主要活性成分,核心靶点可能为AKT1、TNF、IL-6、TP53、SRC,治疗针对的疾病主要有结肠癌、功能性胃肠病、胃炎、炎症性肠病等胃肠疾病和神经胶质瘤、阿尔茨海默病、多发性硬化症、癫痫、中风和孤独症谱系障碍等脑疾病。结论 乌梅丸可能通过核心成分槲皮素、鬃毛酮等作用于AKT1、TNF、IL-6等核心靶点调节肿瘤、HIF-1、钙离子等信号通路发挥治疗胃肠及脑疾病的作用,体现中医"异病同治"的治病法则。
Network Pharmacology and Molecular Docking on Mechanistic Role of Wumei Pills(乌梅丸)"Same Treatment for Different Diseases"in Gastrointestinal and Brain Diseases
Objective To elucidate the mechanism underlying the therapeutic effects of Wumei Pills(乌梅丸)in gastrointesti-nal and neurological diseases through the application of network pharmacology and molecular docking.Methods Traditional Chi-nese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP),PubChem,Swiss Target Prediction,Uniprot,Gen-eCards,BrainBase,STRING,Metascape database and Cytoscape software were used to construct a series of network diagrams and select active compounds,targeted genes and main diseases.The target genes underwent analysis using Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis.Molecular docking verification of key active ingredients and potential targets were performed by AutoDock software.Results A total of 102 active ingredients and 171 intersec-tion targets were screened for the treatment of both gastrointestinal and neurological diseases with Wumei Pills.An enrichment a-nalysis of KEGG pathways entailed several essential signal pathways,such as those in cancer,hepatis B,diabetes complications,HIF-1 and calcium.Quercetin,hispidone,melianone,gomisinB and benzoylnapelline were found to have a role in gastrointesti-nal diseases associated with neurological diseases.PPI network analysis yielded that AKT1,TNF,IL-6,TP53 and SRC can be the key targets mainly treating functional gastrointestinal disorder,inflammatory bowel diseases,colorectal cancer,gastritis,glio-ma,Alzheimer's disease,multiple sclerosis,epilepsy,stroke and austim spectrum disorder.Conclusion The study shows that Wumei Pills may act on AKT1,TNF and IL-6 through core compounds like quercetin and hispidone with pathways such as canc-er,HIF-1 signaling pathway and calcium signaling pathway,thereby treating gastrointestinal and neurological diseases and verif-ying the scientificity of the theory of same treatment for different diseases in modern clinical thinking.

Wumei Pills(乌梅丸)gastrointestinal diseasesneurological diseasesnetwork pharmacologymolecular docking

任雯沁、左佳倩、黄玉洁、舒鹏

展开 >

南京中医药大学,江苏南京 210029

南京中医药大学附属医院,江苏南京 210029

乌梅丸 胃肠疾病 脑疾病 网络药理学 分子对接

2024

实用中医内科杂志
辽宁省中医药学会,中华中医药学会,辽宁省中医药研究院

实用中医内科杂志

影响因子:0.421
ISSN:1671-7813
年,卷(期):2024.38(12)